Keyword: Inflectra


Johnson & Johnson Loses Another Patent Suit

25.01.2018 - US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...


Pfizer Sues J&J over Arthritis Drug

03.10.2017 - Pfizer is suing Johnson & Johnson (J&J) in the US over what it terms anti-competitive practices against its biosimilar Inflectra. The lawsuit is said to be the first of its kind...


European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

01.07.2013 - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...